[{"Assets_0_FY_USD":171415000.0,"CommonStockSharesOutstanding_0_FY_shares":24060510.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-19459000.0,"NetIncomeLoss_1_FY_USD":-8495000.0,"NetIncomeLoss_4_FY_USD":-27115000.0,"StockholdersEquity_0_FY_USD":160225000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190313"}]